Electronic Copy. The parties to this document agree that a copy of the original signature (including an electronic copy) may be used for any and all purposes for which the original signature may have been used. The parties further waive any right to challenge the admissibility or authenticity of this document in a court of law based solely on the absence of an original signature.
Electronic Copy. The parties agree that an electronic copy of this Agreement shall be deemed to be an original of this Agreement for all purposes.
Electronic Copy. The Bank agrees to furnish to each of you, without charge, an electronic copy of the Registration Statement and each amendment thereto, including all financial statements and exhibits thereto, and to furnish to each of the other Underwriters, without charge, an electronic copy of the Registration Statement and each amendment thereto, including such financial statements but without exhibits.
Electronic Copy. The parties to this document agree that a copy of the original signature (including an electronic copy) may be used for any and all purposes for which the original signature may have been used. The parties further waive any right to challenge the admissibility or authenticity of this document in a court of law based solely on the absence of an original signature. The parties execute this Agreement in duplicate originals by their duly authorized officers or representatives. Signature: Name: Title: Date: Signature: Name: Title: Date: Review company’s business plan to develop milestones that fit the licensing situation. Below are ideas for potential milestones: Company viability Financing Management team Manufacturing & operations (build facility or outsource manufacturing) Relationships with suppliers, customers, strategic partners Development Operational prototype Qualification or reliability Telecom: lab trial, field trial Animal studies Government approval FDA: NDA, Phase I, Phase II, etc. Broad commercialization Licensed Product available for sale First sale Net Sales (alternative; ramping annual minimums) Multiple customers
1. has already provided Stanford a preliminary business plan. By , ***** will provide Stanford a detailed document covering *****'s plans as to projected product development, markets and sales forecasts, manufacturing and operations, and financial forecasts until at least $X,000,000 (“Business Plan”). Stanford will treat this Business Plan as confidential information and to protect it as Stanford would its own confidential information.
2. By , ***** will have $X,000,000 of available non-contingent, operating capital to proceed with the exploration and development of Licensed Product. Capital will be from a third party who may or may not be an investor in ***** and unused capital will be on deposit in a financial institutional acceptable to both Stanford and *****.
3. By , ***** will provide to Stanford a listing of the management team or a schedule for the recruitment of key management positions.
4. By , ***** will make a prototype/ begin animal studies.
5. By , ***** will file an NDA, Phase I, Phase II, etc.
6. By , ***** will have a first sale of Licensed Product.
7. or a sublicensee must sell at least 1 Licensed Product every 6 months after the date of first sale of a Licensed Product.
8. By , ***** will reach annual Net Sales of at least $X,000,000.
9. By , ***** will obtain purchase orders from at least 2 customers.
10. By , ***...
Electronic Copy. The Employer will provide the Association with an electronic copy of this Agreement in the Microsoft Word format.
Electronic Copy. The parties to this document agree that a copy of the original signature (including an electronic copy) may be used for any and all purposes for which the original signature may have been used. The parties further waive any right to challenge the admissibility or authenticity of this document in a court of law based solely on the absence of an original signature. The parties execute this Agreement in duplicate originals by their duly authorized officers or representatives. Signature: Name: Title: Date: Signature: Name: Title: Date: Company viability Financing Management team Manufacturing & operations (build facility or outsource manufacturing) Relationships with suppliers, customers, strategic partners Development Operational prototype Qualification or reliability Telecom: lab trial, field trial Animal studies Government approval FDA: NDA, Phase I, Phase II, etc. Broad commercialization Licensed Product available for sale First sale Net Sales (alternative; ramping annual minimums) Multiple customers
1. has already provided Stanford a preliminary business plan. By , ***** will provide Stanford a detailed document covering *****'s plans as to projected product development, markets and sales forecasts, manufacturing and operations, and financial forecasts until at least $X,000,000 (“Business Plan”). Stanford will treat this Business Plan as confidential information and to protect it as Stanford would its own confidential information.
2. By , ***** will have $X,000,000 of available non-contingent, operating capital to proceed with the exploration and development of Licensed Product. Capital will be from a third party who may or may not be an investor in ***** and unused capital will be on deposit in a financial institutional acceptable to both Stanford and *****.
3. By , ***** will provide to Stanford a listing of the management team or a schedule for the recruitment of key management positions.
4. By , ***** will make a prototype/ begin animal studies.
5. By , ***** will file an NDA, Phase I, Phase II, etc.
6. By , ***** will have a first sale of Licensed Product.
7. or a sublicensee must sell at least 1 Licensed Product every 6 months after the date of first sale of a Licensed Product.
8. By , ***** will reach annual Net Sales of at least $X,000,000.
9. By , ***** will obtain purchase orders from at least 2 customers.
10. By , ***** will reach annual Net Sales of at least $XX,000,000.
11. By , ***** will reach annual Net Sales of at least $XXX,000,000.
Electronic Copy. An electronic copy of the supplemental report will be provided along with the hardcopy.
1. Federal Agency and Organizational Element to Which Report is Submitted 2. Federal Grant or Other Identifying Number Assigned by Federal Agency (To report multiple grants, use FFR Attachment) Page of 1 pages
Electronic Copy. The Parties specifically agree that an electronically-maintained, original, signed copy of this Contract and any amendments thereto (“Electronic Copy”) may be utilized for any and all purposes that an original, signed hard copy of this Contract could be utilized, including but not limited to, evidentiary purposes in an administrative, legal or equitable proceeding. To that end, both Parties waive any and all objections that they have or may have to the introduction and use of an Electronic Copy of this Contract in any administrative, legal or equitable proceeding under any rules of evidence, including but not limited to, the so-called “Best Evidence Rule.”
Electronic Copy. See §36.
Electronic Copy. The parties to this document agree that a copy of the original signature (including an electronic copy) may be used for any and all purposes for which the original signature may have been used. The parties further waive any right to challenge the admissibility or authenticity of this document in a court of law based solely on the absence of an original signature. *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request. The parties execute this Agreement in duplicate originals by their duly authorized officers or representatives. THE BOARD OF TRUSTEES OF THE XXXXXX XXXXXXXX JUNIOR UNIVERSITY Signature: /s/ Xxxxxxx Xxxxx Name: Xxxxxxx Xxxxx Title: Acting Director, Office of Technology Licensing Date: March 24, 2015 Alexo Therapeutics International Signature: /s/ Xxxxx Xxxxxxx Name: Xxxxx Xxxxxxx Title: Chair, Board of Directors Date: March 24, 2015 *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request. [***] *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request. Stanford Docket No. S This report is provided pursuant to the license agreement between Stanford University and (Alexo Name) License Agreement Effective Date: Name(s) of Licensed Products being reported: Report Covering Period Yearly Maintenance Fee $ Number of Sublicenses Executed Gross Revenue U.S. Gross Revenue Non-U.S. Gross Revenue $ $ Net Sales U.S. Gross Revenue Non-U.S. Gross Revenue $ $ Royalty Calculation Royalty Subtotal $ Credit $ Royalty Due $ Comments: *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request. The Board of Trustees of the Xxxxxx Xxxxxxxx Junior University (“STANFORD”); and Alexo Therapeutics International a Cayman Islands exempted company, with a mailing address at [951 Xxxxxxx Xxxx, Xxxxx 000, Xxxxx Xxx Xxxxxxxxx, XX 00000], (“ALEXO”); have agreed to use the law firm of (“FIRM”) to prepare, file and prosecute th...
